CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Total revenue	$ 4,413	$ 4,055
Operating expenses
Research and development	39,750	32,126
General and administrative	27,579	26,686
Total operating expenses	67,329	58,812
Loss from operations	(62,916)	(54,757)
Other (expense) income :
Interest income	922	1,251
Interest expense	(5,188)	(688)
Other (expense) income, net	(664)	140
Total other (expense) income	(4,930)	703
Net loss	(67,846)	(54,054)
Other comprehensive income
Foreign currency translation adjustment	13	28
Comprehensive loss	(67,833)	(54,026)
Common Stock
Other comprehensive income
Net loss attributable to shareholders - basic	(67,846)	(54,010)
Net loss attributable to shareholders - diluted	$ (67,846)	$ (54,010)
Weighted shares used in calculating net loss per share - basic (in shares)	300,167,989	270,995,121
Weighted shares used in calculating net loss per share - diluted (in shares)	300,167,989	270,995,121
Net loss per share attributable to shareholders - basic (in USD per share)	$ (0.23)	$ (0.20)
Net loss per share attributable to shareholders - diluted (in USD per share)	$ (0.23)	$ (0.20)
Series B Convertible Preferred Stock
Other comprehensive income
Net loss attributable to shareholders - basic	$ 0	$ (44)
Net loss attributable to shareholders - diluted	$ 0	$ (44)
Weighted shares used in calculating net loss per share - basic (in shares)	0	54,745
Weighted shares used in calculating net loss per share - diluted (in shares)	0	54,745
Net loss per share attributable to shareholders - basic (in USD per share)	$ 0	$ (0.80)
Net loss per share attributable to shareholders - diluted (in USD per share)	$ 0	$ (0.80)
Collaborative arrangement revenue
Total revenue	$ 4,413	$ 4,055
Operating expenses
Research and development	$ 2,000	$ 1,900